Advertise with us
[February 06, 2013]
IMMU, MFLX, NKSH, ENH, G, ITMN Expected To Be Down After Next Earnings Releases
Feb 06, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, February 7th 2013 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. Immunomedics Inc (NASDAQ:IMMU), Multi-Fineline Electronix Inc (NASDAQ:MFLX), National Bankshares Inc (NASDAQ:NKSH), Endurance Specialty Holdings Ltd (NYSE:ENH), Goldcorp Inc (NYSE:G), InterMune Inc (NASDAQ:ITMN) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at
. The following stocks are expected to go Down After earnings are released Thursday: Symbol Company # of Reports Quarter Release Time IMMU Immunomedics Inc 6 Quarter Q2 After MFLX Multi-Fineline Electronix Inc 12 Quarter Q1 After NKSH National Bankshares Inc 6 Quarter Q4 After ENH Endurance Specialty Holdings Ltd February Earnings Q4 After G Goldcorp Inc 12 Quarter Q4 After ITMN InterMune Inc 12 Quarter Q4 After This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Immunomedics Inc (NASDAQ:IMMU) - Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe. Its products include epratuzumab, which is in Phase III trials for the treatment of systemic lupus erythematosus in non-Hodgkin lymphoma and acute lymphoblastic leukemia; Yttrium-90-labeled clivatuzumab tetraxetan, a humanized monoclonal antibody for pancreatic cancer that completed a Phase I/II clinical trials; Veltuzumab, a Phase II clinical study completed product for the treatment of patients with non-Hodgkin s lymphoma and immune thrombocytopenic purpura. The company s early Phase clinical trial products comprise Milatuzumab, a transmembrane protein product, which is in Phase I study for antibody-drug conjugate therapy; Yttrium-90-labeled epratuzumab tetraxetan, a radiolabeled antibody product candidate, in Phase I/II study for patients with non-Hodgkin lymphoma; Labetuzumab-SN-38, which is in Phase I study in patients with colorectal cancer; hRS7-SN-38, a clinical development stage product for breast, cervix, colon and rectum, lung, pancreas, ovary, and prostate cancers. It also develops Dock-and-Lock methodology for making fusion proteins and multifunctional antibodies, as well as a new method of delivering imaging and therapeutic agents selectively to disease, primarily different solid cancers; and markets and sells a diagnostic imaging product, LeukoScan to determine infection and inflammation in bones for patients with suspected osteomyelitis, including patients with diabetic foot ulcers. The company has license and collaboration agreements with Nycomed GmbH; UCB, S.A.; and GE Healthcare LTD. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey..
Multi-Fineline Electronix Inc (NASDAQ:MFLX) - Multi-Fineline Electronix, Inc. engages in the engineering, design, and manufacture of flexible printed circuit boards and related component assemblies for the electronics industry. The company offers integrated flexible printed circuits and component assembly solutions, such as design and application engineering, prototyping, high-volume fabrication, component assembly, and testing. It serves original equipment manufacturer and electronic manufacturing service providers in the electronics industry for applications, such as mobile phones and smart phones, tablets, consumer products, portable bar code scanners, computer/data storage, and medical devices. The company operates in the United States, China, Singapore, Malaysia, Korea, and the United Kingdom. Multi-Fineline Electronix, Inc. was founded in 1984 and is headquartered in Irvine, California..
National Bankshares Inc (NASDAQ:NKSH) - National Bankshares, Inc. operates as the bank holding company for the National Bank of Blacksburg, which provides a range of retail and commercial banking services to individuals, businesses, non-profits, and local governments in Virginia. It offers demand deposit accounts, money market deposit accounts, savings accounts and certificates of deposit; commercial, agricultural, real estate, home equity, and consumer loans; merchant credit card services, and business and consumer debit and credit cards; letters of credit, night depository, safe deposit boxes, travelers checks, utility payment services, and automatic funds transfer; and telephone and Internet banking services. The company operates 25 office locations and 25 automated teller machines in southwest Virginia. It also conducts a general trust business that provides wealth management, and trust and estate services for individual and business customers. In addition, the company, through its subsidiary, National Bankshares Financial Services, Inc., offers non-deposit investment products and insurance products. National Bankshares, Inc. was founded in 1891 and is headquartered in Blacksburg, Virginia..
Endurance Specialty Holdings Ltd (NYSE:ENH) - Endurance Specialty Holdings Ltd. underwrites specialty lines of personal and commercial property and casualty insurance and reinsurance worldwide. Its Insurance segment offers agriculture insurance covering traditional multi-peril crop insurance, crop hail, livestock risk protection, and other agriculture risk management products; and professional lines of insurance products, including directors and officers liability, errors and omissions, employment practices liability, environmental liability, and pension trust liability insurance. This segment also offers casualty insurance comprising third party liability insurance; property insurance for various industries; healthcare liability line focusing on hospital medical professional liability insurance; and surety and other specialty products, such as contract and commercial surety, and workers compensation. The company s Reinsurance segment provides catastrophe reinsurance for catastrophic perils primarily for property and workers compensation business; casualty reinsurance for reinsuring third party liability exposures, such as automobile, professional, directors and officers , and umbrella liabilities, as well as workers compensation; and property reinsurance for individual property insurance policies. It also provides aerospace reinsurance covering hull, aircraft liability, and aircraft products; marine reinsurance of bluewater and brownwater hull, and cargo risks; surety reinsurance for contract and commercial surety, as well as for fidelity insurance coverages; personal accident and terrorism reinsurance products; agriculture reinsurance for risks associated with the production of food and fiber; and traditional treaty, and stop loss reinsurance for primary insurance companies writing multiple peril, hail, and named peril covers, as well as custom risk transfer mechanisms for agricultural dependent industries. The company was founded in 2001 and is based in Pembroke, Bermuda..
Goldcorp Inc (NYSE:G) - Genpact Limited provides business process and technology management services worldwide. Its finance and accounting services include accounts payable services, payment and inquiry management, order to cash services, preparation of financial statements, closing and reporting, cash management, treasury, cash flow analysis, tax return preparation, financial planning and analysis, governance, and internal controls services; and supply chain and procurement services comprise sourcing and procurement, demand forecasting and management, engineering, inventory optimization and planning, fleet and logistics, and aftermarket services. The company also provides smart decision services comprising re-engineering services to help clients in improving or designing processes; analytics services to assess a new business opportunity, mitigate market risks, or retain and build market share; and risk management services, such as internal audit, Sarbanes-Oxley compliance advisory services, and regulatory advisory services, as well as enterprise, information technology (IT), and fraud risk management services. In addition, the company offers enterprise application services comprising enterprise resource planning, supply chain management, financial management, and customer relationship management solutions, as well as testing, database administration, and architecture services, and securities trading and accounting; IT management services consisting of consulting and management of data centers, servers, storage, emails, networks services, security services, production support, identity management, and database management; and collections and customer services in the areas of consumer finance, commercial finance, and mortgage services. It primarily serves banking and insurance, capital markets, consumer packaged goods and retail, pharmaceuticals, manufacturing, and healthcare industries. The company was founded in 1997 and is based in Hamilton, Bermuda..
InterMune Inc (NASDAQ:ITMN) - InterMune, Inc., a biotechnology company, engages in the research, development, and commercialization of therapies in pulmonology and orphan fibrotic diseases. The company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It markets Pirfenidone, an orally active small molecule drug for the treatment of adults with mild to moderate IPF under the Esbriet name in the European Union. The company s Pirfenidone is also in Phase III clinical trials for the treatment of IPF in the United States. In addition, it offers Pirfenidone under the Pirespa trade name for the treatment of IPF in Japan; Pirfenex trade name in India; and Shanghai Genomics in China. InterMune, Inc. was founded in 1998 and is headquartered in Brisbane, California..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Buyins.net Thomas Ronk firstname.lastname@example.org www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
on the world wide web. Inquiries to email@example.com.
Back To NFVZone's Homepage